Chronic lung disease, chronic obstructive pulmonary disease, interstitial lung disease, pulmonary fibrosis
Conditions
Interventions
None listed
Sponsors
Mie University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Population Studies involving adult patients with chronic lung disease will be included. Eligible diseases include chronic obstructive pulmonary disease (COPD), interstitial lung disease, and pulmonary fibrosis. Participants must be aged 18 years or older. 2. Concept: Intervention This review will include breathing technique interventions alone that aim to relieve dyspnea. Eligible interventions include, but are not limited to: pursed-lip breathing diaphragmatic breathing abdominal breathing deep breathing exercises breathing control mindful breathing other interventions primarily based on breathing techniques There will be no restrictions on intervention duration. Single-session, short-term, and long-term interventions will all be included. Studies in which breathing techniques are provided in addition to usual care will also be included. 3. Context There will be no restrictions on the setting. Studies conducted in hospitals, outpatient clinics, home settings, rehabilitation facilities, community settings, or other settings will be included. 4. Study Design Intervention studies will be included. Eligible study designs include: randomized controlled trials crossover trials quasi-experimental studies pre-post studies single-arm intervention studies 5. Outcomes Studies that include an assessment of dyspnea will be included. Eligible outcome measures include, but are not limited to: Borg scale modified Medical Research Council dyspnea scale (mMRC) Visual Analog Scale (VAS) Numerical Rating Scale (NRS) Baseline Dyspnea Index/Transition Dyspnea Index (BDI/TDI) University of California, San Diego Shortness of Breath Questionnaire (UCSD SOBQ) Quality-of-life measures will also be included if they contain dyspnea-related items or subscales. 6. Language and Publication Type Original articles published in English or Japanese will be included.
Exclusion criteria
Exclusion criteria: 1. Ineligible diseases or populations Studies targeting patients with acute respiratory failure, postoperative patients, patients receiving mechanical ventilation, or healthy participants only will be excluded. 2. Studies targeting diseases other than chronic lung disease Studies primarily targeting diseases other than chronic lung disease will be excluded. Studies targeting patients with cancer will also be excluded. 3. Studies in which the intervention is not a breathing technique alone Studies evaluating multicomponent interventions that combine breathing techniques with other components will be excluded. Examples include interventions combined with exercise therapy, muscle strengthening, inspiratory muscle training, yoga as a whole program, tai chi, singing, psychological therapy, educational programs, inhaler instruction, or telerehabilitation. However, studies in which breathing techniques are provided in addition to usual care will be included. 4. Studies without dyspnea-related outcomes Studies that do not assess dyspnea-related outcomes will be excluded. For example, studies evaluating only pulmonary function, SpO2, exercise tolerance, or respiratory muscle activity without assessing dyspnea will be excluded. 5. Ineligible study designs or publication types Reviews, protocols, case reports, case series, qualitative studies, observational studies, cross-sectional studies, commentaries, and conference abstracts without full-text articles will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of this scoping review will be the specific procedures of breathing technique interventions alone. Extracted information will include the name of the breathing technique, definition of the technique, description of the breathing method, posture during practice, duration per session, frequency, intervention period, instructor, method of instruction, whether the technique was self-administered, relationship with usual care, and information relevant to intervention reproducibility. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes of this scoping review will be the basic characteristics of included studies, participant and disease characteristics, types and timing of dyspnea-related outcome measures, reported findings, safety, and feasibility. Extracted information will include authors, publication year, country, study design, setting, target disease, age and disease severity of participants, sample size, comparator, dyspnea measurement tools, timing of assessment, dyspnea-related findings, adverse events, adherence, dropout rates, and implementation-related issues. | — |
Countries
Japan
Contacts
Public ContactYohei Kishi
Mie University Graduate School of Medicine
Outcome results
None listed